KCA-1490 is a dual inhibitor of phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4), exhibiting IC50 values of 369 nM and 42 nM, respectively. This compound demonstrates significant bronchodilatory and anti-inflammatory effects, effectively suppressing histamine-induced bronchoconstriction in vivo. KCA-1490 is a valuable tool for research into asthma and chronic obstructive pulmonary disease (COPD) pathways and therapeutic strategies.
KCA-1490 is a dual inhibitor of phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4), exhibiting IC50 values of 369 nM and 42 nM, respectively. This compound demonstrates significant bronchodilatory and anti-inflammatory effects, effectively suppressing histamine-induced bronchoconstriction in vivo. KCA-1490 is a valuable tool for research into asthma and chronic obstructive pulmonary disease (COPD) pathways and therapeutic strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: